Eric R Hantz

10PUBLICATIONS
48CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active moleculesDeep learningMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 16, 2026
Structure-Based Design of Reversible, Quinoline-2(1H)‑one Inhibitors of Serine- and Metallo-Carbapenemases.

Lian M C Jacobs, Priyadarshini Jaishankar, Jeffrey Zheng

|Jan 09, 2026
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens.

Jongbin Kim, Galen J Correy, Brendan W Hall

|Jan 06, 2026
Discovery of Coronavirus Main Protease Inhibitors with Enhanced Brain Exposure and Potent Oral Efficacy in SARS-CoV-2 and MERS Infection Models.

Luca Lizzadro, Jiapeng Li, Taha Y Taha

|Dec 17, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In Vivo.

Priyadarshini Jaishankar, Galen J Correy, Yusuke Matsui

|Apr 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy.

Tyler C Detomasi, Gilles Degotte, Sijie Huang

|Aug 02, 2023
Applications of machine learning in computer-aided drug discovery.

Sm Bargeen Alam Turzo, Eric R Hantz, Steffen Lindert

Pageof 2

Frequent Collaborators

5 joint publications

Steffen Lindert

5 joint publications

Adam R Renslo

4 joint publications

Brian K Shoichet

4 joint publications

Nevan J Krogan